Literature DB >> 31456102

Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Shiyu Wang1, Tao Wang1, Qingqing Xiang1, Min Xiao1, Yao Cao1, Huan Xu1, Shujuan Li1, Wen Tian1, Xiaodong Zhao2, Xuemei Tang3, Liping Jiang4.   

Abstract

PURPOSE: Chronic granulomatous disease (CGD) is the most common phagocyte defect disease. Here, we describe 114 CGD patients in our center and report a rare female infant with XL-CGD to provide a better understanding of diagnosis, treatment, and prenatal diagnosis of CGD.
METHOD: Patients were diagnosed by DHR-1,2,3 flow cytometry assays and gene analysis. X chromosome inactivation analysis and gp91phox protein test were used for a female infant with XL-CGD.
RESULTS: XL-CGD accounts for the majority of cases in China and results in higher susceptibility to some infections than AR-CGD. The DHR assay can help diagnose CGD quickly, and atypical results should be combined with clinical manifestations, genetic analysis, and regular follow-up. For prenatal diagnosis, both gDNA and cDNA genotypes of amniotic fluid cells should be identified, and cord blood DHR assays should be performed to identify female XL-CGD patients.

Entities:  

Keywords:  Chronic granulomatous disease; X inactivation; dihydrorhodamine-1,2,3 assay; gene analysis; prenatal diagnosis

Mesh:

Substances:

Year:  2019        PMID: 31456102     DOI: 10.1007/s10875-019-00680-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  54 in total

1.  [A multicenter study of reference intervals for 15 laboratory parameters in Chinese children].

Authors:  X H Zhong; J Ding; J H Zhou; Z H Yu; S Z Sun; Y Bao; J H Mao; L Yu; Z H Li; Z M Han; H M Song; X Y Jiang; Y L Liu; B L Zhang; Z K Xia; C H Jin; G H Zhu; M Wang; S P Feng; Y Shen; S M Huang; Q S Ma; H X Li; X J Wang; K Ichihara; C Yao; C Y Dong
Journal:  Zhonghua Er Ke Za Zhi       Date:  2018-11-02

2.  Altered pattern of Naïve and memory B cells and B1 cells in patients with chronic granulomatous disease.

Authors:  Monireh Mohsenzadegan; Fahimeh Fattahi; Fatemeh Fattahi; Abbas Mirshafiey; Mohammad Reza Fazlollahi; Fariba Naderi Beni; Masoud Movahedi; Zahra Pourpak
Journal:  Iran J Allergy Asthma Immunol       Date:  2014-06       Impact factor: 1.464

Review 3.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 4.  Chronic granulomatous disease.

Authors:  Dirk Roos
Journal:  Br Med Bull       Date:  2016-03-16       Impact factor: 4.291

5.  Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization.

Authors:  A Rösen-Wolff; W Soldan; K Heyne; J Bickhardt; M Gahr; J Roesler
Journal:  Ann Hematol       Date:  2001-02       Impact factor: 3.673

Review 6.  Chronic Granulomatous Disease.

Authors:  Amit Rawat; Sagar Bhattad; Surjit Singh
Journal:  Indian J Pediatr       Date:  2016-02-11       Impact factor: 1.967

7.  A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.

Authors:  Pooja Khandelwal; Jacob J Bleesing; Stella M Davies; Rebecca A Marsh
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-16       Impact factor: 5.742

8.  Random X inactivation resulting in mosaic nullisomy of region Xp21.1----p21.3 associated with heterozygosity for ornithine transcarbamylase deficiency and for chronic granulomatous disease.

Authors:  U Francke
Journal:  Cytogenet Cell Genet       Date:  1984

9.  Itraconazole to prevent fungal infections in chronic granulomatous disease.

Authors:  John I Gallin; David W Alling; Harry L Malech; Robert Wesley; Deloris Koziol; Beatriz Marciano; Eli M Eisenstein; Maria L Turner; Ellen S DeCarlo; Judith M Starling; Steven M Holland
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

Review 10.  Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.

Authors:  Sarah E Henrickson; Artemio M Jongco; Kelly F Thomsen; Elizabeth K Garabedian; Isaac P Thomsen
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

View more
  3 in total

1.  De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.

Authors:  Lang Yu; Wenhui Li; Ge Lv; Gan Sun; Lu Yang; Junjie Chen; Lina Zhou; Yuan Ding; Zhiyong Zhang; Xuemei Tang; Yunfei An; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2022-08-23       Impact factor: 8.542

2.  Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.

Authors:  Amit Rawat; Pandiarajan Vignesh; Murugan Sudhakar; Madhubala Sharma; Deepti Suri; Ankur Jindal; Anju Gupta; Jitendra Kumar Shandilya; Sathish Kumar Loganathan; Gurjit Kaur; Sanchi Chawla; Pratap Kumar Patra; Alka Khadwal; Biman Saikia; Ranjana Walker Minz; Vaishali Aggarwal; Prasad Taur; Ambreen Pandrowala; Vijaya Gowri; Mukesh Desai; Manasi Kulkarni; Gauri Hule; Umair Bargir; Priyanka Kambli; Manisha Madkaikar; Sagar Bhattad; Chetan Ginigeri; Harish Kumar; Ananthvikas Jayaram; Deenadayalan Munirathnam; Meena Sivasankaran; Revathi Raj; Ramya Uppuluri; Fouzia Na; Biju George; Harsha Prasada Lashkari; Manas Kalra; Anupam Sachdeva; Shishir Seth; Tapas Sabui; Aman Gupta; Karin van Leeuwen; Martin de Boer; Koon Wing Chan; Kohsuke Imai; Osamu Ohara; Shigeaki Nonoyama; Yu Lung Lau; Surjit Singh
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

3.  Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease.

Authors:  Timothy Lok-Hin Chiu; Daniel Leung; Koon-Wing Chan; Hok Man Yeung; Chung-Yin Wong; Huawei Mao; Jianxin He; Pandiarajan Vignesh; Weiling Liang; Woei Kang Liew; Li-Ping Jiang; Tong-Xin Chen; Xiang-Yuan Chen; Yin-Bo Tao; Yong-Bin Xu; Hsin-Hui Yu; Alta Terblanche; David Christopher Lung; Cheng-Rong Li; Jing Chen; Man Tian; Brian Eley; Xingtian Yang; Jing Yang; Wen Chin Chiang; Bee Wah Lee; Deepti Suri; Amit Rawat; Anju Gupta; Surjit Singh; Wilfred Hing Sang Wong; Gilbert T Chua; Jaime Sou Da Rosa Duque; Kai-Ning Cheong; Patrick Chun-Yin Chong; Marco Hok-Kung Ho; Tsz-Leung Lee; Wanling Yang; Pamela P Lee; Yu Lung Lau
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.